Zevra Therapeutics gains on upbeat Q2 results

Zevra Therapeutics

14/08/2023 19:10

** Shares of rare disease therapeutics co Zevra Therapeutics
Inc  ZVRA.O  up 1.4% at $5.27
    ** Co posts Q2 revenue of $8.47 mln, above analysts' est. of
$3.03 mln
    ** Co reports Q2 loss of 15 cents per share vs analysts est.
of a loss of 34 cents
    ** Ends Q2 2023 with $87.4 mln in cash, cash equivalents,
and investments; supporting our forecast cash runway into 2026,
says co
    ** ZVRA shares up 14.4% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))